الفهرسة نشطة
للباحثين للناشرين تسجيل الدخول إنشاء حساب
الرئيسية المؤلفون Madiha Iqbal
MI

Madiha Iqbal

h-4 H-Index
39 Citations
8 Papers

Published Papers

8 indexed
1
Lisocabtagene Maraleucel in Relapsed or Refractory Diffuse Large B Cell Lymphoma
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.1016/j.hemonc.2021.09.004
12 citations 394
2
Management of CAR T-cell Related Toxicities
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1029
8 citations 390
3
Intraocular involvement of Mantle cell lymphoma
Hematology/Oncology and Stem Cell Therapy Q3 2021 10.1016/j.hemonc.2019.03.002
7 citations 387
4
Efficacy of Allogeneic Hematopoietic Cell Transplantation in Patients With Chronic Phase CML Resistant or Intolerant to Tyrosine Kinase Inhibitors
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.1016/j.hemonc.2021.02.003
6 citations 393
5
Understanding the Etiology of Pancytopenias in the CAR T-Cell Therapy Setting
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1047
4 citations 390
6
Association of thrombosis and mortality in patients with COVID-19 infections: a hospital-based observational study
The Egyptian Journal of Internal Medicine Q2 2022 10.1186/s43162-022-00153-5
1 citations 381
7
Relapse of Hodgkin lymphoma after autologous hematopoietic cell transplantation
Hematology/Oncology and Stem Cell Therapy Q3 2021 10.1016/j.hemonc.2020.05.011
1 citations 390
8
Effect of Somatic Variants Post Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Hematology/Oncology and Stem Cell Therapy Q3 2025 10.4103/hemoncstem.hemoncstem-d-25-00029
0 citations 392

Publication Activity

Journals Published In

The Egyptian Journal of Internal Medicine
🇪🇬 Q2 AMS 94
Hematology/Oncology and Stem Cell Therapy
🇸🇦 Q3 AMS 72